<!DOCTYPE html>
<html>

	<head>
		
		<title>natUIve</title>
		<meta charset=utf-8>
		<meta name=viewport content='width=device-width,initial-scale=1.0,maximum-scale=1.0,user-scalable=no'>
		<link rel=styleSheet href=../include/natuive.css type=text/css media=screen>
		<!--[if lte IE 9]> 
			<link rel=styleSheet href=../include/ie.css type=text/css media=screen>
			<script src=../include/html5shiv.min.js></script> 
		<![endif]-->
		
	</head>
		
	<body>
	
		<!-- Header and Banner - Start -->
	
		<div class=header-and-banner>
		
			<header>
				
				<div class=contain>
				
					<nav class="drop">
						
						<ul>
							
							<li class="active"> <a href>Home</a> </li>						
							<li> <a href>About</a> </li>						
							<li class="active"> <a href>People</a> </li>						
						
						</ul>
						
					</nav>
				
				</div>
	
			</header>
	
			<div class=banner>
				
				<div class="slider">
				
					<div>					
					
						<div class=contain>
		
							<h2>Annual Report 2014</h2>
							
							<p>Imperial Innovations has published its Annual Report and Accounts for the year ended 31 July 2014. Click the button below to visit the Annual Report website.</p>
							
							<a class="button big" href>View Website</a>
						
						</div>
						
					</div>
			
					<div>					
					
						<div class=contain>
		
							<h2>Imperial Innovations</h2>
							
							<p>We are focused on commercialising the best in UK academic research, drawn from academic centres within the 'golden triangle' formed by Cambridge, Oxford and London. We have end-to-end capability, taking research at the earliest stage and working with it right through to commercialisation.</p>
							
							<a class="button big" href>Read more</a>
						
						</div>
						
					</div>
			
					<div>					
					
						<div class=contain>
		
							Banner
						
						</div>
						
					</div>
				
				</div>
			
			</div>
			
		</div>
	
		<!-- Header and Banner - End -->

		<!-- Content - Start -->
		
		<main id=content>
		
			<div class="row contain">
				
				<div>
					
					<h3>Imperial Innovations</h3>
					
					<p>We are a technology commercialisation company, combining the activities of technology transfer, intellectual property licensing and protection, company incubation and investment. We are focused on the commercialisation of the most promising opportunities from a broad range of technology sectors, with particular expertise in therapeutics, medtech, engineering & materials and ICT.</p>
					
					<a class="button" href>About us</a> <a class="button" href>Our people</a> <a class="button" href>Investor relations</a>
					
				</div>
			
				<div>
					
					<div class="slider">
						
						<div>
							
							<div class="row">
								
								<div>
									
									<h4>£198.3m</h4>
									
									<h5>invested in UK innovation</h5>
									
									<p>During the six months ended 31 January 2015 we invested £22.4 million in our portfolio.</p>
									
								</div>
							
								<div>
									
									<h4>£346.0m</h4>
									
									<h5>Raised by Innovations</h5>
									
									<p>to support investment in and development of our portfolio of technology businesses</p>
									
								</div>
							
							</div>
							
						</div>
						
						<div>
							
							<div class="row">
								
								<div>
									
									<h4>£1 billion</h4>
									
									<h5>invested in UK innovation</h5>
									
									<p>Alongside co-investors, £1 billion has been committed to our portfolio companies since 2006</p>
									
								</div>
							
								<div>
									
									<h4>£1.4 billion</h4>
									
									<h5>Research Funding</h5>
									
									<p>received each year by the universities we focus on (Imperial, Oxford, Cambridge, UCL)</p>
									
								</div>
							
							</div>
							
						</div>
						
						<div>
							
							<div class="row">
								
								<div>
									
									<h4>£22.4m</h4>
									
									<h5>Invested</h5>
									
									<p>During the six months ended 31 January 2015 we invested £22.4 million in our portfolio.</p>
									
								</div>
							
								<div>
									
									<h4>35</h4>
									
									<h5>Accelerated Growth Companies</h5>
									
									<p>The focus of our time and capital</p>
									
								</div>
							
							</div>
							
						</div>
						
					</div>
					
				</div>
				
			</div>
			
			<div class="row contain">
				
				<div>
					
					<div class="headline-icon">
						
						<img src="" alt="Technology Transfer">
						
						<p>Technology Transfer</p>
					
					</div>
					
					<h4>Our Technology Transfer team works with Imperial College London academics and students.</h4>
					
					<p>We manage the translation of an idea into practice, working with academic inventors throughout the process of commercialisation, leading ultimately to licensing to industry partners, or the creation of new ventures</p>
					
					<a href class="button">Find out more</a>
					
				</div>
			
				<div>
					
					<div class="headline-icon">
						
						<img src="" alt="Ventures">
						
						<p>Ventures</p>
					
					</div>
					
					<h4>Our ventures team creates, nurtures and invests in new technology ventures based on IP</h4>
					
					<p>We work to develop new company opportunities based on leading UK academic research, working with Imperial College London (& our own Technology Transfer team), The Universities of Oxford & Cambridge and UCL.</p>
					
					<a href class="button">Find out more</a>
					
				</div>
			
			</div>
			
			<div class="row contain">
				
				<div>
					
					<h4>Imperial Innovations news</h4>
					
					<a href class="button">More news</a>
				
				</div>

			</div>				

			<div class="row contain">
				
				<div class="col23">
					
					<div class="row">
						
						<div class="col3">
						
							<img src='' alt="News">
						
						</div>
						
						<div>
							
							<h5><a href>Innovations obtains further £50m loan facility from EIB to strengthen UK biotech & life science investment</a></h5>
							
							<p>£50 million loan facility will strengthen investment rate and scale in medtech ...</p>
							
							<a href>Read article</a>
							
						</div>
					
					</div>
					
					<div class="row">
						
						<div class="col3">
						
							<img src='' alt="News">
						
						</div>
						
						<div>
							
							<h5><a href>Encouraging trial results for cystic fibrosis gene therapy treatment</a></h5>
							
							<p>£Imperial Innovations is pleased to note the announcement this morning that a ...</p>
							
							<a href>Read article</a>
							
						</div>
					
					</div>
					
				</div>
				
				<div>
					
					<div class="row">
						
						<div class="col4">
						
							<b>09</b> Oct
						
						</div>
						
						<div>
							
							<h5><a href>Imperial Innovations wins 'Best Communications' award at the 2015 AIM Awards</a></h5>
							
							<a href>Read article</a>
							
						</div>
					
					</div>
					
					<div class="row">
						
						<div class="col4">
						
							<b>05</b> Oct
						
						</div>
						
						<div>
							
							<h5><a href>Inflowmatix appoints CEO and other industry experts to senior management team</a></h5>
							
							<a href>Read article</a>
							
						</div>
					
					</div>
					
					<div class="row">
						
						<div class="col4">
						
							<b>02</b> Oct
						
						</div>
						
						<div>
							
							<h5><a href>Innovations portfolio company wins OBN Award</a></h5>
							
							<a href>Read article</a>
							
						</div>
					
					</div>
					
				</div>
			
			</div>
					
			<div class="row contain">
				
				<div>
					
					<h4>Portfolio overview</h4>
					
					<a href class="button">View portfolio</a>
				
				</div>

			</div>				
	
			<div class="row contain">
				
				<div>
					
					<p>We have identified four particular areas of expertise, shown in the diagram below. As at 31 January 2015, the value of the top 20 investments in our portfolio stood at £241.3 million.</p>
					
					<div class="row">
						
						<div>

							<h5>Portfolio subsectors</h5>
							
							<ul>
								
								<li>Therapeutics</li><li>Medtech</li><li>Engineering/Materials</li><li>ICT/Digital</li>
								
							</ul>
							
							<a href>More about our leading investments</a>
						
						</div>
						
						<div>
							
							<img src='' alt="Diagram">
							
						</div>
					
					</div>
					
				</div>
				
				<div>
					
					<div class="slider">
						
						<div>
							
							<img src='' alt="Circassia">
							
							<table>
								
								<thead>
									
									<tr>
										
										<td>Sector</td>
										
										<td>Investment amount</td>
										
										<td>Investment stage</td>
									</tr>
								
								</thead>
								
								<tr>
									
									<td>Therapeutics</td>
									
									<td>£25.5m</td>
									
									<td>Listed</td>
								
								</tr>
							
							</table>
							
							<h5>Overview</h5>
							
							<p>A clinical-stage specialty biopharmaceutical company developing a range of novel immunotherapies</p>
							
							<a href>View profile</a>
						
						</div>
						
						<div>
							
							<img src='' alt="Orthonika">
							
							<table>
								
								<thead>
									
									<tr>
										
										<td>Sector</td>
										
										<td>Investment amount</td>
										
										<td>Investment stage</td>
									</tr>
								
								</thead>
								
								<tr>
									
									<td>Medtech</td>
									
									<td></td>
									
									<td>Seed</td>
								
								</tr>
							
							</table>
							
							<h5>Overview</h5>
							
							<p>Complete replacement for knee meniscus</p>
							
							<a href>View profile</a>
						
						</div>
						
						<div>
							
							<img src='' alt="Circassia">
							
							<table>
								
								<thead>
									
									<tr>
										
										<td>Sector</td>
										
										<td>Investment amount</td>
										
										<td>Investment stage</td>
									</tr>
								
								</thead>
								
								<tr>
									
									<td>Therapeutics</td>
									
									<td>£25.5m</td>
									
									<td>Listed</td>
								
								</tr>
							
							</table>
							
							<h5>Overview</h5>
							
							<p>A clinical-stage specialty biopharmaceutical company developing a range of novel immunotherapies</p>
							
							<a href>View profile</a>
						
						</div>
						
					</div>
					
				</div>
			
			</div>
					
			<div class="row contain">
				
				<div>
					
					<h4>Investment details</h4>
					
					<a href class="button">View</a>
				
				</div>

			</div>
			
			<div class="row contain">
				
				<div>
					
					<h5>Share price: 482.50p</h5>
					
					<img src='' alt="Diagram">
					
				</div>
				
				<div>
					
					<h5>Key information</h5>
					
					<p>
						
						Sector: Financial Services<br>
						Activities: Technology commercialisation, incubation and investment<br>
						EPIC: IVO<br>
						Status: AIM<br>
						Year end: 31 July
						
					</p>
				
				</div>
			
			</div>			
	
		</main>
		
		<!-- Content - End -->
	
		<!-- Footer - Start -->
		
		<footer>
			
			<div class=contain>
				
				<h3>Stay up to date with our innovations newsletter</h3>
				
				<a href class="button">Sign up</a>
				
			</div>	
	
			<div class='row contain'>
				
				<div>
					
					<h2>About Imperial Innovations</h2>
					
					<p><b>Seeking to build substantial, high quality, well-funded and well-managed businesses</b></p>
					
					<p>Imperial Innovations is a technology commercialisation company that combines the activities of technology transfer, intellectual property protection and licensing, company incubation, and investment.</p>
				
				</div>
		
				<div>
					
					<h2>Contact & location information</h2>
					
					<a href>View our other locations</a>
					
					<p><b>Imperial Innovations - London office</b></p>
					
					<div class="row">
						
						<div>
							
							52 Princes Gate<br>
							Exhibition Road<br>
							London<br>
							SW7 2PG
						
						</div>
						
						<div>
							
							Telephone: + 44 (0) 203 053 8850<br>
							Fax: +44 (0) 20 7589 8987<br>
							Email: info@imperialinnovations.co.uk<br>
						
						</div>	
					
					</div>		
				
				</div>
		
			</div>
							
		</footer>
	
		<!-- Footer - End -->
	
		<script src=../include/natuive.min.js type=text/javascript></script>
	
	</body>

</html>
